These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1235 related articles for article (PubMed ID: 16999640)

  • 41. Recruiting high risk women into a breast cancer health promotion trial.
    Lerman C; Rimer BK; Daly M; Lustbader E; Sands C; Balshem A; Masny A; Engstrom P
    Cancer Epidemiol Biomarkers Prev; 1994; 3(3):271-6. PubMed ID: 8019378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implications of living with a strong family history of breast cancer.
    Maheu C
    Can J Nurs Res; 2009 Jun; 41(2):100-12. PubMed ID: 19650516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service.
    Miller SM; Fleisher L; Roussi P; Buzaglo JS; Schnoll R; Slater E; Raysor S; Popa-Mabe M
    J Health Commun; 2005; 10 Suppl 1():119-36. PubMed ID: 16377604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bilateral prophylactic mastectomy decision making: A vignette study.
    Stefanek M; Enger C; Benkendorf J; Flamm Honig S; Lerman C
    Prev Med; 1999 Sep; 29(3):216-21. PubMed ID: 10479610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of breast cancer risk counseling for sexual minority women.
    Bowen DJ; Powers D; Greenlee H
    Health Care Women Int; 2006 Jan; 27(1):59-74. PubMed ID: 16338740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
    Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
    Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coping with genetic testing for breast cancer susceptibility.
    Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A
    Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
    Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
    Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire.
    Erblich J; Brown K; Kim Y; Valdimarsdottir HB; Livingston BE; Bovbjerg DH
    Patient Educ Couns; 2005 Feb; 56(2):182-91. PubMed ID: 15653247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
    Paterniti DA; Melnikow J; Nuovo J; Henderson S; DeGregorio M; Kuppermann M; Nease R
    Ethn Dis; 2005; 15(3):365-72. PubMed ID: 16108294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
    Lewis MJ; Peterson SK
    Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pilot trial of a computerized decision aid for breast cancer prevention.
    Ozanne EM; Annis C; Adduci K; Showstack J; Esserman L
    Breast J; 2007; 13(2):147-54. PubMed ID: 17319855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health literacy and cancer risk perception: implications for genomic risk communication.
    Brewer NT; Tzeng JP; Lillie SE; Edwards AS; Peppercorn JM; Rimer BK
    Med Decis Making; 2009; 29(2):157-66. PubMed ID: 19050227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer worry and mammography use by women with and without a family history in a population-based sample.
    Andersen MR; Smith R; Meischke H; Bowen D; Urban N
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):314-20. PubMed ID: 12692105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intention to pursue genetic testing for breast cancer among women due for screening mammography.
    Gwyn K; Vernon SW; Conoley PM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):96-102. PubMed ID: 12582018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In the moment: women speak about surgical treatment decision making days after a breast cancer diagnosis.
    Lally RM
    Oncol Nurs Forum; 2009 Sep; 36(5):E257-65. PubMed ID: 19726385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The meaning of risk to first degree relatives of women with breast cancer.
    Sheinfeld Gorin S; Albert SM
    Women Health; 2003; 37(3):97-117. PubMed ID: 12839310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer worry in women with hereditary risk factors for breast cancer.
    Loescher LJ
    Oncol Nurs Forum; 2003; 30(5):767-72. PubMed ID: 12949589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.